Loading...
Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion
Infusion of allogeneic NK cells is a potential immunotherapy for both hematopoietic malignancies and solid tumors. Interactions between killer immunoglobulin-like receptors (KIR) on human NK cells and KIR-ligands on tumor cells influence the magnitude of NK function. To obtain sufficient numbers of...
Na minha lista:
Udgivet i: | Cancer Immunol Immunother |
---|---|
Main Authors: | , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Springer Berlin Heidelberg
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5477646/ https://ncbi.nlm.nih.gov/pubmed/27392940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-016-1864-z |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|